(INNS)
TRINBELIMAB(INND)
TRINBELIMAB(INNC)
IMMUNOGLOBULIN G1-LAMBDA3, ANTI-[HOMO SAPIENS RHD (RHESUS BLOOD GROUP D ANTIGEN, RHD, CD240D)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-460) [VH (HOMO SAPIENS IGHV1-69*06 (92.9%) -(IGHD) - IGHJ6*01 (88.9%) V124>I (126), CDR-IMGT [8.8.23] (26-33.51-58.97-119)) (1-130) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (227) (131- 228), HINGE 1-15 (229-243), CH2 (244-353), CH3 D12 (369), L14 (371) (354-458), CHS (459-460)) (131- 460)], (233-215')-DISULFIDE WITH LAMBDA3 LIGHT CHAIN HOMO SAPIENS (1'-216') [V-LAMBDA (HOMO SAPIENS IGLV2-14*03 (94.9%) -IGLJ2*01 (100%), CDR-IMGT [9.3.10] (26-34.52-54.91-100)) (1'-110') -HOMO SAPIENS IGLC3*03 (100%) (111'-216')]; DIMER (239-239'':242- 242'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-DXB11 CELL LINE, GLYCOFORM ALFA(WHO)
TRINBELIMABUM(INN)